AOD-9604 is primarily investigated in preclinical research involving lipolysis and metabolic signaling.

Key research areas include:

• Lipolysis: Experimental research examines AOD-9604 in relation to fat-breakdown pathways in adipose-tissue models.
• Lipogenesis: Studies investigate its relationship with processes involved in lipid storage and synthesis.
• Metabolic research: AOD-9604 has been explored in experimental models examining metabolic parameters.
• Body-composition research: Preclinical studies investigate changes in body fat and related endpoints.
• Cartilage research: Some experimental models have examined AOD-9604 in connection with cartilage and joint-related processes.

These are areas of preclinical investigation. They should not be interpreted as evidence that AOD-9604 is a treatment for obesity, weight management, joint conditions, or any other medical condition.

What makes AOD-9604 different?

AOD-9604 is structurally related to the 177-191 region of human growth hormone, but it is a modified peptide with an N-terminal tyrosine.

Its research profile is also distinct because studies focus on selective metabolic and lipolytic activity rather than the broader biological actions associated with intact growth hormone.

For researchers comparing AOD-9604 with other research peptides, its defined sequence, molecular specifications, and stated research focus provide useful points of distinction.

Why choose this AOD-9604 research peptide?

When evaluating an AOD-9604 peptide for sale, researchers can review the material's molecular identity, purity, physical form, and supplied reconstitution materials.

This product is specified at ≥99% HPLC purity and is supplied as a lyophilized powder. A 3mL vial of 0.6% acetic acid is included with each purchase to support the specified laboratory reconstitution process.

The product also provides a defined CAS number, molecular formula, molar mass, sequence, and storage information for researchers who require detailed material identification.

AOD-9604 reconstitution and handling

AOD-9604 is supplied as a lyophilized powder and, according to the supplied product information, can present gelling, cloudiness, increased viscosity, or aggregation during reconstitution.

The product information identifies 0.6% acetic acid as the primary reconstitution solution and 0.9% bacteriostatic water as an additional laboratory solvent.

For laboratory handling, the supplied guidance recommends allowing the lyophilized material and reconstitution solution to reach room temperature before preparation. The acetic acid solution should be introduced carefully, followed by gentle mixing rather than vigorous agitation.

Further dilution with bacteriostatic water may be used in laboratory workflows when appropriate for the research protocol. Researchers should determine the appropriate preparation conditions for their specific experimental application.

Important handling considerations

Gelling or increased viscosity can occur during AOD-9604 reconstitution, including when using the supplied 0.6% acetic acid solution. According to the supplied product information, this behavior is associated with the material's reconstitution characteristics and does not by itself establish degradation or loss of purity.

Researchers should follow the supplied handling instructions carefully and minimize contamination risks during laboratory preparation.

The supplier does not replace or refund material affected by improper reconstitution, unsuitable solvents, excessive agitation, temperature mishandling, contamination, or other handling-related issues.

Storage and handling

The supplied specifications indicate −20°C (−4°F) for long-term storage and 2–8°C (36–46°F) after reconstitution.

Researchers should follow the product documentation and applicable laboratory procedures for storage, preparation, and handling. Maintaining appropriate temperature conditions is particularly important when working with lyophilized or reconstituted research materials.

What should researchers know before ordering?

If you are comparing AOD-9604 suppliers or looking to buy AOD-9604 online, review the actual product specifications rather than relying on broad claims such as “fat-loss peptide.”

Important details include the peptide's molecular identity, sequence, purity, physical form, storage requirements, and the solvents supplied for laboratory reconstitution.

AOD-9604 is a research material, and its preclinical metabolic findings should not be presented as established human weight-loss or therapeutic outcomes.

Frequently asked questions

What is AOD-9604?

AOD-9604 is a modified C-terminal fragment of human growth hormone corresponding to the hGH 177-191 region with an added N-terminal tyrosine. It is studied in preclinical research involving lipolytic and metabolic pathways.

What is the CAS number for AOD-9604?

The listed CAS number is 221231-10-3.

What is the molecular formula of AOD-9604?

The supplied molecular formula is C78H123N23O23S2.

What is the molar mass of AOD-9604?

The listed molar mass is 1815.1 g/mol.

What form is AOD-9604 supplied in?

AOD-9604 is supplied as a lyophilized powder.

What is included with AOD-9604?

Each purchase includes a 3mL vial of 0.6% acetic acid solution for laboratory reconstitution.

Why can AOD-9604 become cloudy or gel-like?

According to the supplied product information, AOD-9604 can develop increased viscosity, cloudiness, or gel formation during reconstitution because of its reconstitution characteristics. Appropriate laboratory preparation and handling can help manage these properties.

What solvents are listed for AOD-9604?

The supplied specifications list 0.6% acetic acid and 0.9% bacteriostatic water for laboratory use.

How should AOD-9604 be stored?

The supplied specifications list −20°C (−4°F) for long-term storage and 2–8°C (36–46°F) after reconstitution.

Is AOD-9604 intended for human use?

No. This product is intended for laboratory research only and is not for human or veterinary consumption.

Product overview

AOD-9604 is a modified hGH 177-191 peptide fragment with an added N-terminal tyrosine, studied in preclinical research involving lipolysis, lipid metabolism, body-composition endpoints, and related metabolic pathways.

The material is supplied as a lyophilized powder with ≥99% HPLC purity and has a defined CAS number of 221231-10-3, molecular formula of C78H123N23O23S2, and molar mass of 1815.1 g/mol.

Each purchase includes a 3mL vial of 0.6% acetic acid solution for laboratory reconstitution. The supplied specifications also list 0.9% bacteriostatic water for laboratory use and provide specific storage conditions for both the lyophilized and reconstituted material.

For researchers evaluating an AOD-9604 metabolism peptide, the defined molecular specifications, purity, reconstitution materials, and handling information provide the essential details needed for informed laboratory evaluation.

For laboratory research only. Not for human or veterinary consumption.